arrow
P

Petra Štěrbová-Kovaříková

faculty of pharmacy in hradec kralove
H指数:9
被引数:237

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery and Pharmacological Profiling of Quinoline- and Quinoxaline-Based Phenoxypropanoic Acid Derivatives as Multitarget Modulators of PPARα, FXR, and LXRα receptors

喹啉基和喹喔啉基苯氧基丙酸衍生物的发现及其作为PPARα、FXR和LXRα受体多靶点调节剂的药理学表征

2026-10-270
OAAI
A new bactericidal chlorinated derivative containing 2-aminooxazole potentiates antibacterial action of colistin against multidrug-resistant acinetobacter baumannii

一种含有2-氨基噁唑烷酮的新型杀菌性氯代衍生物增强了多黏菌素对鲍曼不动杆菌的抗菌作用

2025-09-190
OA
Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotection

Topobexin靶向Topoisomerase II ATPase结构域,以实现β异构体选择性抑制和蒽环类心脏保护。

2025-05-280
OA
Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation

右雷佐生对蒽环类药物心脏毒性的临床上可翻译的预防是由拓扑异构酶II β 介导的,而不是金属螯合

2021-11-0139
OA
Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIβ Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity
2020-06-0114
OAAI
EFFECTIVE CARDIOPROTECTION AGAINST ANTHRACYCLINE CARDIOTOXICITY IN ISOLATED CARDIOMYOCYTES AND RABBITS IS BASED ON DEXRAZOXANE INTERACTION WITH TOPOISOMERASE II BETA INSTEAD OF IRON CHELATION BY ITS METABOLITE ADR-925
HEART
IF4.4
2019-05-010
OAAI